Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Astellas
Biotech
A look at how Roche's $1.5B Poseida buyout came together
In 2023, Roche's James Sabry told the biotech that the pharma wasn't likely to be interested in buying Poseida at that time.
Gabrielle Masson
Dec 10, 2024 12:30pm
Biopharma layoff rate stabilizes in Q3: Fierce Biotech analysis
Oct 4, 2024 3:50pm
Melodia sings $275M song for Alivexis' cathepsin C inhibitor
Jun 21, 2024 5:07am
Bayer posts pivotal data on rival to Astellas in menopause space
May 17, 2024 6:45am
Bayer to take menopause drug to regulators after 3rd ph. 3 win
Mar 19, 2024 7:17am
Astellas puts the cork back in $350M Xork deal with Cartesian
Mar 14, 2024 10:41am
